Joo-Hang Kim
- Oncology top 0.1%
- Pulmonary and Respiratory Medicine top 0.1%
- Molecular Biology top 2%
- Cancer Research top 1%
- Immunology top 2%
- Co-authors
- Myung‐Ju AhnEnriqueta FelipDong‐Wan KimJi‐Youn HanEdward B. GaronMary J. FidlerGilberto de CastroGregory M. Lubiniecki
- Topics
- Lung Cancer Treatments and Mutations (76 papers)Lung Cancer Research Studies (40 papers)Colorectal Cancer Treatments and Studies (29 papers)
- Partner nations
- South KoreaUnited StatesFrance
In The Last Decade
Joo-Hang Kim
148 papers receiving 11.5k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 8.3k
- Pulmonary and Respiratory Medicine 6.7k
- Molecular Biology 3.1k
- Cancer Research 1.6k
- Immunology 1.4k
Countries citing papers authored by Joo-Hang Kim
This map shows the geographic impact of Joo-Hang Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joo-Hang Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joo-Hang Kim more than expected).
Fields of papers citing papers by Joo-Hang Kim
This network shows the impact of papers produced by Joo-Hang Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joo-Hang Kim. The network helps show where Joo-Hang Kim may publish in the future.
Co-authorship network of co-authors of Joo-Hang Kim
This figure shows the co-authorship network connecting the top 25 collaborators of Joo-Hang Kim. A scholar is included among the top collaborators of Joo-Hang Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joo-Hang Kim. Joo-Hang Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 4 | |
| 3 | 31 | |
| 4 | 18 | |
| 5 | 25 | |
| 6 | 23 | |
| 7 | 28 | |
| 8 | 11 | |
| 9 | 7 | |
| 10 | 2 | |
| 11 | 69 | |
| 12 | 81 | |
| 13 | 23 | |
| 14 | 16 | |
| 15 | 26 | |
| 16 | MAGRIT phase III trial in adjuvant NSCLC: MAGE-A3 gene expression frequency on the first 2150 patients screened and demographics of first patients randomized | 2 |
| 17 | 54 | |
| 18 | 9 | |
| 19 | 16 | |
| 20 | 28 |
About Joo-Hang Kim
Joo-Hang Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 150 papers that have together received 11.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (76 papers), Lung Cancer Research Studies (40 papers) and Colorectal Cancer Treatments and Studies (29 papers). The work is most often cited by research in Oncology (8.3k citations), Pulmonary and Respiratory Medicine (6.7k citations) and Cancer Research (1.6k citations). Joo-Hang Kim has collaborated with scholars based in South Korea, United States and France. Frequent co-authors include Myung‐Ju Ahn, Enriqueta Felip, Dong‐Wan Kim, Ji‐Youn Han, Edward B. Garon, Mary J. Fidler, Gilberto de Castro, Gregory M. Lubiniecki, Roy S. Herbst and Paul Baas. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.